Feed AALR3.SA
AA

Allianca Saude e Participacoes S.A.

AALR3.SA · SAO

R$ 3.30 +0.00% (+R$ 0.00)
1M +0.00%
Market Cap R$ 536.2M
P/E Ratio -
Div. Yield -
ROE 187.77%

Bulios Fair Price

R$ 2.42

26.7% downside

Current Price

R$ 3.3

Undervalued Fair Value Overvalued

According to Bulios Fair Price, AALR3.SA is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Weak
3/9
Valuation
85 /100
Cheap
P/S 0.46x
P/FCF 10.77x
EV/EBITDA 11.55x
Growth
28 /100
Declining
Book val. growth 2.34%
Rev. growth 2.31%
FCF growth N/A
Profitability
16 /100
Weak
FCF margin 4.32%
Op. margin 4.59%
Gross margin 20.54%
Quality
8 /100
Poor
Asset turnover 0.65x
ROA 77.21%
ROIC 11.46%
Debt
0 /100
High
Int. coverage -0.15x
Net debt/EBITDA 6.00x
Current ratio 0.28x
Stability
50 /100
Moderate
Profitable years 0
EPS volatility 2,286.07%
Beta 0.52x

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about AALR3.SA
Online

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Ricardo de Magalhaes Sartim

Employees

5,800

Headquarters

São Paulo

Upcoming events

13 NOV

Earnings

Upcoming earnings report

42d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.